A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

GEP Introduces a Free Portal & Service to Connect Health Care Providers: Beginning with Hospitals in New York, New Jersey & Connecticut with PPE Suppliers

GEP, a leading provider of procurement and supply chain strategy, software and managed services to Fortune 500 companies, introduced a free portal — www.gep.com/covid19help/ — and service to connect health care providers — beginning with hospitals in the New York, New Jersey and Connecticut — with personal protective equipment (PPE) suppliers.

This service combines an online portal with the company’s procurement and supply chain specialists, for:

  1. Suppliers – with PPE equipment (N-95 masks, surgical masks, ventilators, isolation gowns, etc.) to be connected with the health care providers in need.
  2. Manufacturers/small businesses – to be connected with subject-matter experts for help in distributing excess capacity, repurposing equipment, or packaging.
  3. Health care providers – to provide details of their required PPE products to be connected with suppliers in GEP’s database.

GEP has proactively provided details of suppliers with PPE equipment to tri-state’s major hospital networks since mid-March. It is launching this portal to scale its effort to identify and connect the PPE suppliers with the health care providers.

SourceGEP
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy